BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9211677)

  • 1. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.
    Musch DC; Martin DF; Gordon JF; Davis MD; Kuppermann BD
    N Engl J Med; 1997 Jul; 337(2):83-90. PubMed ID: 9211677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.
    Martin DF; Kuppermann BD; Wolitz RA; Palestine AG; Li H; Robinson CA
    N Engl J Med; 1999 Apr; 340(14):1063-70. PubMed ID: 10194235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.
    Drew WL; Ives D; Lalezari JP; Crumpacker C; Follansbee SE; Spector SA; Benson CA; Friedberg DN; Hubbard L; Stempien MJ
    N Engl J Med; 1995 Sep; 333(10):615-20. PubMed ID: 7637721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
    Squires KE
    AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.
    Duker JS; Robinson M; Anand R; Ashton P
    Ophthalmic Surg Lasers; 1995; 26(5):442-8. PubMed ID: 8963859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cytomegalovirus retinitis in AIDS with an intraocular sustained-release ganciclovir implant].
    Mochizuki M; Ikeda E; Yoshimura K; Hikita N; Nagata Y; Iwamoto A; Fujino Y; Eguchi S; Oka S; Kimura S
    Nippon Ganka Gakkai Zasshi; 1998 Aug; 102(8):515-21. PubMed ID: 9754023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA; Matheron S
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganciclovir ocular implant: new preparation. May benefit severely affected AIDS patients.
    Prescrire Int; 1998 Jun; 7(35):77-8. PubMed ID: 10342923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group.
    AIDS; 1995 May; 9(5):471-7. PubMed ID: 7639972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravitreal ganciclovir in cytomegalovirus retinitis in AIDS].
    Olea JL; Salvat M; Mateos JM; Vila J; Villalonga C; Riera M
    Rev Clin Esp; 1996 Apr; 196(4):208-12. PubMed ID: 8701057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.
    Martin DF; Parks DJ; Mellow SD; Ferris FL; Walton RC; Remaley NA; Chew EY; Ashton P; Davis MD; Nussenblatt RB
    Arch Ophthalmol; 1994 Dec; 112(12):1531-9. PubMed ID: 7993207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA; Rutledge BK; Morley MG; Duker JS
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.
    Spector SA; McKinley GF; Lalezari JP; Samo T; Andruczk R; Follansbee S; Sparti PD; Havlir DV; Simpson G; Buhles W; Wong R; Stempien M
    N Engl J Med; 1996 Jun; 334(23):1491-7. PubMed ID: 8618603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of CMV retinitis with intravitreal foscarnet].
    Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
    J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.
    Hatton MP; Duker JS; Reichel E; Morley MG; Puliafito CA
    Retina; 1998; 18(1):50-5. PubMed ID: 9502281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis.
    Guembel HO; Krieglsteiner S; Rosenkranz C; Hattenbach LO; Koch FH; Ohrloff C
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):824-9. PubMed ID: 10502057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pars plana implantation of a ganciclovir drug carrier in patients with cytomegalovirus retinitis and AIDS. Indications, follow-up and postoperative complications].
    Gümbel H; Rosenkranz C; Schnaudigel OE; Mauck K; Fries U; Ohrloff C
    Ophthalmologe; 1997 Oct; 94(10):713-8. PubMed ID: 9432239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.